PHARMACEUTICAL COMPOUNDS

A compound which is an arylimidazolyl isoxazole of formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HARBOTTLE Gareth, SHANNON Jonathan, PAOLETTA Silvia, PEGG Neil Anthony, BROWN Richard James, ONIONS Stuart Thomas, TADDEI David Michel Adrien, SMYTH Don
Format: Patent
Sprache:eng ; slv
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!